Hotline
+88 018777-71133
Investigation Support
+88 018445-22301
Medicine Support
+88 018445-22302
Open Hours
Hotline
Investigation Support
Medicine Support
Open Hours
Inf. Lactoride 500 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v is a medicine, menufectured by BEXIMCO Pharma. It contains Hartmann's Solution
| SKU | PRO-03-0002158 |
|---|---|
| Dosage | Inf. |
| Brand Name | Lactoride 500 |
| Generic | Hartmann's Solution |
| Strength | 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v |
| Manufacturer | BEXIMCO Pharma |
| Pack | Piece | MRP | ARTO Price |
|---|---|---|---|
| Single | 1 | 71.09 BDT | 71.09 BDT |
| Box | 1 pcs | 71.09 BDT | 71.09 BDT |
| Cartoon | X | X | X |
Before taking Inf. Lactoride 500 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v, inform your doctor if you or your child have liver or kidney problems or any allergies. It should be used with caution in patients with liver problems due to alcohol to prevent the risk of liver damage.
Inf. Lactoride 500 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v should be used with caution in pregnant women only if clearly advised by the doctor and can be used in breastfeeding women.
Inf. Lactoride 500 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v is not recommended for use in children less than 10 years of age and should be used with caution in elderly patients.
Consult your doctor if you experience any side effects or unusual effects during treatment with Inf. Lactoride 500 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v.
It is unsafe to consume alcohol with Inf. Lactoride 500 0. 6 % w/v + 0. 04% w/v + 0. 027% w/v + 0. 32% w/v
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
